Is it common for a professional athlete to have the option of returning just 10 days after a medial collateral ligament ...

Only 33 days after suffering a knee injury that looked to be much worse than it was, Packers quarterback Jordan Love has ...

The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...

Acalabrutinib, a Bruton tyrosine kinase inhibitor, is currently approved under the brand name Calquence ® for MCL in patients who have received at least 1 prior therapy. It is also indicated for the ...

According to NFL Media, Moses is expected to miss two to four weeks with an MCL sprain and bone bruise. In steps Olu Fashanu at right tackle, the No. 11 overall pick in the 2024 NFL Draft.

New therapeutic strategies that target cell pathways deregulated in these tumours are opening new possibilities for the treatment of patients with MCL. Specifically, compounds that interfere with ...

Starting right tackle Morgan Moses has avoided a season-ending injury. Tests confirmed he only suffered a sprained MCL and bone bruise in the third quarter of Thursday night’s win over the ...

AstraZeneca's supplemental New Drug Application for Calquence (acalabrutinib) has been granted Priority Review by the US FDA ...

Acalabrutinib, a BTK inhibitor, has shown promising results in treating mantle cell lymphoma, with the FDA granting it ...

TAMPA, Fla. -- Tampa Bay Buccaneers star defensive tackle Vita Vea suffered a Grade 2 MCL sprain to his right knee and will be "day-to-day," coach Todd Bowles said Monday. "Right now, he's day-to ...